开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2024-07-12 ms7000000563451718 来自江苏省

巨特么慢，去年三月份投的稿现在还在外审

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2024-01-23 12唐布拉来自浙江省

太慢了，一个月还在找审稿人

185 0

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2022-06-08 贵中医

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：药理
经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！

81 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2023-07-10 ms1000001069261709 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：外审完了，中间没有出现under review 状态

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2023-02-12 ms7000000525998320 来自福建省

2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！

75 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2023-06-21 ms3000000528495608 来自辽宁省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：免疫抑制;脓毒症
经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。

91 0

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2022-12-11 jiafeimao123 来自上海

审稿速度:24.0 | 投稿命中率:5.0
经验分享：一切都太慢了，没有之一

85 0

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2021-11-16 话雨临风

外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌

125 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2021-10-20 146d554dm18暂无昵称

为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回

109 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2214649, encodeId=13e2221464954, content=巨特么慢，去年三月份投的稿现在还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80a66531437, createdName=ms7000000563451718, createdTime=Fri Jul 12 18:16:31 CST 2024, time=2024-07-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183390, encodeId=d31921833900e, content=太慢了，一个月还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b44e5483545, createdName=12唐布拉, createdTime=Tue Jan 23 10:42:47 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1225249, encodeId=22fe122524929, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：药理 经验分享：论文修回后一直是editor assigned快1个月了，无语了！要收要拒痛快点！磨磨唧唧的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0a761673882, createdName=贵中医, createdTime=Wed Jun 08 18:41:18 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147344, encodeId=d169214e344dd, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：外审完了，中间没有出现under review 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3868200180, createdName=ms1000001069261709, createdTime=Mon Jul 10 21:07:18 CST 2023, time=2023-07-10, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2114217, encodeId=7937211421e71, content=2023.2.6提交 2.7editor assigned 2.8under review 2.10reviewers assigned 第一个under review应该不是外审，而是学术编辑的review，接下来持续更新，祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dd8225338, createdName=ms7000000525998320, createdTime=Sun Feb 12 12:14:33 CST 2023, time=2023-02-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2144067, encodeId=1bf5214406ed0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：免疫抑制;脓毒症 经验分享：分配了两个审稿人，一个同意，一个让小修，修了三四个月才接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11978274176, createdName=ms3000000528495608, createdTime=Wed Jun 21 10:58:19 CST 2023, time=2023-06-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2105320, encodeId=c5c021053203c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：一切都太慢了，没有之一, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/3e89e688a15b4b399673908d8617a0ae/ab0a0bdeba5e4dcdb873d9a9867e5714.jpg, createdBy=98a31643603, createdName=jiafeimao123, createdTime=Sun Dec 11 00:55:54 CST 2022, time=2022-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1070768, encodeId=b7ce10e07681e, content=外审一个多月，审稿意见回来reviews complete两星期了。编辑还没有做决定，心里好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e995108255, createdName=话雨临风, createdTime=Tue Nov 16 14:13:39 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062316, encodeId=b85010623163d, content=为什么先是审稿人被安排又是审稿子又变成审稿人被安排啊，发邮件也没人回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eefa5170147, createdName=146d554dm18暂无昵称, createdTime=Wed Oct 20 17:43:18 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185742, encodeId=be441185e427a, content=杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f7d5544009, createdName=ms1000001425393231, createdTime=Tue Jan 18 20:26:28 CST 2022, time=2022-01-18, status=1, ipAttribution=)]

2022-01-18 ms1000001425393231

杂志最近回复邮件超级蛮，近期有同行遇到同样迟迟不回复邮件的情况吗？

81 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务